Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients
/in International Publications, Pancreatic Cancer /von 2000-08-01 / Int J Colorectal Dis 2000 Aug;15(4):197-205External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma
/in Hyperthermia, International Publications, Prostate Cancer /von 2000-07-15 / Cancer 2000 Jul;89(2):399-403Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein
/in International Publications, Pancreatic Cancer /von 2000-07-01 / J. Immunother. 2000 Jul-Aug;23(4):464-72Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
/in Hyperthermia, International Publications /von 2000-06-05 / J. Exp. Med. 2000 Jun;191(11):1957-64Use of mild, whole body hyperthermia in cancer therapy
/in Hyperthermia, International Publications /von 2000-05-01 / Immunol. Invest. 2000 May;29(2):139-42Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
/in Cervical Cancer, Colorectal Cancer, Hyperthermia, International Publications /von 2000-04-01 / Lancet 2000 Apr;355(9210):1119-25HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
/in Hyperthermia, International Publications /von 2000-04-01 / Nat. Med. 2000 Apr;6(4):435-42[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma]
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2000-03-17 / Dtsch. Med. Wochenschr. 2000 Mar;125(11):317-9Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-16
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de